Surgeons test wrapping trick to prevent pancreatic leaks after whipple
NCT ID NCT06630910
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way to reconnect the pancreas to the intestine during Whipple surgery for certain cancers. The new method uses a stent and wraps the connection with omentum (fatty tissue) to try to prevent leaks. 48 patients were split into two groups to compare the new technique with the standard one.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- surgical procedure (pancreaticojejunostomy with stenting and omental wrapping)
- What this could lead to
- If successful, this new surgical technique could reduce serious complications like pancreatic fistula after Whipple surgery.
- What could go wrong
- This is a small, single-center study with only 48 patients. The results may not apply to all hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
48 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Mar 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Resectable tumors of the duodenum, ampulla, distal common bile duct, and pancreatic head. * ASA I, II. Exclusion Criteria: * Irresectability criteria (such as metastases, ascites, or arterial vascular invasion) * ASA III, IV.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ampullary tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Theodor Bilharz Research Institute
Giza, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can chemo before surgery extend lives in pancreatic cancer?
- Could a simple stitch prevent a common complication after pancreatic surgery?
- New biopsy technique may spot hidden abdominal cancers without major surgery
- Glue and omental wrap may cut pancreatic surgery risks
- New tool could better predict duodenal cancer in FAP patients
- Scientists revisit endoscopic cancer removal to find best techniques